UniProt ID | M3K7_HUMAN | |
---|---|---|
UniProt AC | O43318 | |
Protein Name | Mitogen-activated protein kinase kinase kinase 7 | |
Gene Name | MAP3K7 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 606 | |
Subcellular Localization |
Cytoplasm . Cell membrane Peripheral membrane protein Cytoplasmic side . Although the majority of MAP3K7/TAK1 is found in the cytosol, when complexed with TAB1/MAP3K7IP1 and TAB2/MAP3K7IP2, it is also localized at the cell membrane. |
|
Protein Description | Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signal transduction of TRAF6, various cytokines including interleukin-1 (IL-1), transforming growth factor-beta (TGFB), TGFB-related factors like BMP2 and BMP4, toll-like receptors (TLR), tumor necrosis factor receptor CD40 and B-cell receptor (BCR). Ceramides are also able to activate MAP3K7/TAK1. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K1/MEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs, c-jun N-terminal kinases (JNKs) and I-kappa-B kinase complex (IKK). Both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1), while nuclear factor-kappa B is activated by IKK. MAP3K7 activates also IKBKB and MAPK8/JNK1 in response to TRAF6 signaling and mediates BMP2-induced apoptosis. In osmotic stress signaling, plays a major role in the activation of MAPK8/JNK1, but not that of NF-kappa-B. Promotes TRIM5 capsid-specific restriction activity.. | |
Protein Sequence | MSTASAASSSSSSSAGEMIEAPSQVLNFEEIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQYSDEGQSNSATSTGSFMDIASTNTSNKSDTNMEQVPATNDTIKRLESKLLKNQAKQQSESGRLSLGASRGSSVESLPPTSEGKRMSADMSEIEARIAATTAYSKPKRGHRKTASFGNILDVPEIVISGNGQPRRRSIQDLTVTGTEPGQVSSRSSSPSVRMITTSGPTSEKPTRSHPWTPDDSTDTNGSDNSIPMAYLTLDHQLQPLAPCPNSKESMAVFEQHCKMAQEYMKVQTEIALLLQRKQELVAELDQDEKDQQNTSRLVQEHKKLLDENKSLSTYYQQCKKQLEVIRSQQQKRQGTS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
28 | Ubiquitination | APSQVLNFEEIDYKE CCHHEECHHHCCCCE | 8.56 | 22817900 | |
63 | Ubiquitination | RAKDVAIKQIESESE HHHHEEEHHCCCHHH | 35.17 | 24816145 | |
67 | Phosphorylation | VAIKQIESESERKAF EEEHHCCCHHHHHHH | 48.31 | 20068231 | |
69 | Phosphorylation | IKQIESESERKAFIV EHHCCCHHHHHHHHH | 52.56 | 20068231 | |
69 (in isoform 2) | Phosphorylation | - | 52.56 | - | |
69 (in isoform 3) | Phosphorylation | - | 52.56 | - | |
69 (in isoform 4) | Phosphorylation | - | 52.56 | - | |
72 | Ubiquitination | IESESERKAFIVELR CCCHHHHHHHHHHHH | 43.53 | - | |
79 | Ubiquitination | KAFIVELRQLSRVNH HHHHHHHHHHHCCCC | 23.14 | 22817900 | |
158 | Ubiquitination | ALIHRDLKPPNLLLV EEECCCCCCCCEEEE | 63.82 | 22817900 | |
169 | Phosphorylation | LLLVAGGTVLKICDF EEEEECCEEEEECCC | 23.03 | 28258704 | |
178 | Phosphorylation | LKICDFGTACDIQTH EEECCCCCCCEEEHH | 24.89 | 22817900 | |
184 | Acetylation | GTACDIQTHMTNNKG CCCCEEEHHCCCCCC | 17.59 | 22802624 | |
184 | Phosphorylation | GTACDIQTHMTNNKG CCCCEEEHHCCCCCC | 17.59 | 22817900 | |
184 (in isoform 2) | Phosphorylation | - | 17.59 | - | |
184 (in isoform 3) | Phosphorylation | - | 17.59 | - | |
184 (in isoform 4) | Phosphorylation | - | 17.59 | - | |
187 | Acetylation | CDIQTHMTNNKGSAA CEEEHHCCCCCCCCE | 28.21 | 22802624 | |
187 | Phosphorylation | CDIQTHMTNNKGSAA CEEEHHCCCCCCCCE | 28.21 | 21512573 | |
187 (in isoform 2) | Phosphorylation | - | 28.21 | - | |
187 (in isoform 3) | Phosphorylation | - | 28.21 | - | |
187 (in isoform 4) | Phosphorylation | - | 28.21 | - | |
192 | Phosphorylation | HMTNNKGSAAWMAPE HCCCCCCCCEEECCC | 19.20 | 15590691 | |
192 (in isoform 2) | Phosphorylation | - | 19.20 | - | |
192 (in isoform 3) | Phosphorylation | - | 19.20 | - | |
192 (in isoform 4) | Phosphorylation | - | 19.20 | - | |
206 | Phosphorylation | EVFEGSNYSEKCDVF CHHCCCCCHHCCCHH | 21.65 | - | |
209 | Ubiquitination | EGSNYSEKCDVFSWG CCCCCHHCCCHHHHH | 29.78 | 22817900 | |
216 | Ubiquitination | KCDVFSWGIILWEVI CCCHHHHHHHHHHHH | 8.89 | 22817900 | |
221 | Ubiquitination | SWGIILWEVITRRKP HHHHHHHHHHHCCCC | 22.16 | 22817900 | |
228 | Ubiquitination | EVITRRKPFDEIGGP HHHHCCCCCCCCCCH | 39.86 | 24816145 | |
269 | Ubiquitination | LMTRCWSKDPSQRPS HHHHHHCCCHHHCCC | 49.51 | 29967540 | |
304 | Phosphorylation | PLQYPCQYSDEGQSN CCCCCCCCCCCCCCC | 25.47 | 28348404 | |
305 | Phosphorylation | LQYPCQYSDEGQSNS CCCCCCCCCCCCCCC | 11.87 | 28348404 | |
310 | Phosphorylation | QYSDEGQSNSATSTG CCCCCCCCCCCCCCC | 43.54 | 28348404 | |
312 | Phosphorylation | SDEGQSNSATSTGSF CCCCCCCCCCCCCCE | 37.86 | 28348404 | |
314 | Phosphorylation | EGQSNSATSTGSFMD CCCCCCCCCCCCEEC | 27.00 | 28348404 | |
315 | Phosphorylation | GQSNSATSTGSFMDI CCCCCCCCCCCEECH | 30.41 | 28348404 | |
316 | Phosphorylation | QSNSATSTGSFMDIA CCCCCCCCCCEECHH | 32.27 | 28348404 | |
318 | Phosphorylation | NSATSTGSFMDIAST CCCCCCCCEECHHCC | 19.93 | 28348404 | |
331 | Phosphorylation | STNTSNKSDTNMEQV CCCCCCCCCCCHHHC | 54.65 | 25849741 | |
333 | Phosphorylation | NTSNKSDTNMEQVPA CCCCCCCCCHHHCCC | 43.48 | 25849741 | |
335 | Sulfoxidation | SNKSDTNMEQVPATN CCCCCCCHHHCCCCH | 4.07 | 21406390 | |
341 | Acetylation | NMEQVPATNDTIKRL CHHHCCCCHHHHHHH | 27.79 | 22520462 | |
341 | Phosphorylation | NMEQVPATNDTIKRL CHHHCCCCHHHHHHH | 27.79 | 30576142 | |
344 | Phosphorylation | QVPATNDTIKRLESK HCCCCHHHHHHHHHH | 30.39 | 30576142 | |
346 | Ubiquitination | PATNDTIKRLESKLL CCCHHHHHHHHHHHH | 53.69 | 21906983 | |
346 (in isoform 1) | Ubiquitination | - | 53.69 | 21890473 | |
346 (in isoform 2) | Ubiquitination | - | 53.69 | 21890473 | |
346 (in isoform 3) | Ubiquitination | - | 53.69 | 21906983 | |
351 | Ubiquitination | TIKRLESKLLKNQAK HHHHHHHHHHHHHHH | 48.76 | 22817900 | |
354 | Ubiquitination | RLESKLLKNQAKQQS HHHHHHHHHHHHHHC | 58.41 | - | |
358 | Ubiquitination | KLLKNQAKQQSESGR HHHHHHHHHHCCCCC | 38.82 | 24816145 | |
361 | Phosphorylation | KNQAKQQSESGRLSL HHHHHHHCCCCCCCC | 31.10 | 30266825 | |
363 | Phosphorylation | QAKQQSESGRLSLGA HHHHHCCCCCCCCCC | 34.16 | 30266825 | |
367 | Phosphorylation | QSESGRLSLGASRGS HCCCCCCCCCCCCCC | 24.32 | 30266825 | |
371 | Phosphorylation | GRLSLGASRGSSVES CCCCCCCCCCCCCCC | 35.06 | 30266825 | |
374 | Phosphorylation | SLGASRGSSVESLPP CCCCCCCCCCCCCCC | 30.05 | 28450419 | |
375 | Phosphorylation | LGASRGSSVESLPPT CCCCCCCCCCCCCCC | 32.50 | 25159151 | |
378 | Phosphorylation | SRGSSVESLPPTSEG CCCCCCCCCCCCCCC | 43.98 | 28450419 | |
382 | Phosphorylation | SVESLPPTSEGKRMS CCCCCCCCCCCCCCC | 37.15 | 23090842 | |
383 | O-linked_Glycosylation | VESLPPTSEGKRMSA CCCCCCCCCCCCCCC | 50.56 | 30059200 | |
383 | Phosphorylation | VESLPPTSEGKRMSA CCCCCCCCCCCCCCC | 50.56 | 23090842 | |
386 | Acetylation | LPPTSEGKRMSADMS CCCCCCCCCCCCCHH | 40.66 | 30592829 | |
389 | Phosphorylation | TSEGKRMSADMSEIE CCCCCCCCCCHHHHH | 25.75 | 29255136 | |
389 (in isoform 2) | Phosphorylation | - | 25.75 | 25849741 | |
389 (in isoform 3) | Phosphorylation | - | 25.75 | - | |
389 (in isoform 4) | Phosphorylation | - | 25.75 | 25849741 | |
393 | Phosphorylation | KRMSADMSEIEARIA CCCCCCHHHHHHHHH | 35.65 | 23927012 | |
393 (in isoform 2) | Phosphorylation | - | 35.65 | 23322592 | |
393 (in isoform 4) | Phosphorylation | - | 35.65 | 23322592 | |
402 | Phosphorylation | IEARIAATTAYSKPK HHHHHHHHHCCCCCC | 11.70 | 28258704 | |
402 | Ubiquitination | IEARIAATTAYSKPK HHHHHHHHHCCCCCC | 11.70 | 24816145 | |
402 (in isoform 2) | Phosphorylation | - | 11.70 | 23322592 | |
402 (in isoform 4) | Phosphorylation | - | 11.70 | 23322592 | |
403 | Phosphorylation | EARIAATTAYSKPKR HHHHHHHHCCCCCCC | 20.90 | 28258704 | |
403 (in isoform 3) | Phosphorylation | - | 20.90 | - | |
405 | Phosphorylation | RIAATTAYSKPKRGH HHHHHHCCCCCCCCC | 18.35 | 28152594 | |
406 | Phosphorylation | IAATTAYSKPKRGHR HHHHHCCCCCCCCCC | 39.76 | 28152594 | |
406 (in isoform 3) | Phosphorylation | - | 39.76 | - | |
412 | Phosphorylation | YSKPKRGHRKTASFG CCCCCCCCCCCCCCC | 31.90 | 32142685 | |
412 (in isoform 2) | Phosphorylation | - | 31.90 | 25849741 | |
412 (in isoform 4) | Phosphorylation | - | 31.90 | 25849741 | |
415 | Phosphorylation | PKRGHRKTASFGNIL CCCCCCCCCCCCCCC | 27.73 | 30278072 | |
417 | Phosphorylation | RGHRKTASFGNILDV CCCCCCCCCCCCCCC | 38.63 | 30278072 | |
417 (in isoform 2) | Phosphorylation | - | 38.63 | 25849741 | |
417 (in isoform 4) | Phosphorylation | - | 38.63 | 25849741 | |
419 (in isoform 2) | Phosphorylation | - | 20.13 | - | |
419 (in isoform 4) | Phosphorylation | - | 20.13 | - | |
427 | Phosphorylation | NILDVPEIVISGNGQ CCCCCCEEEECCCCC | 2.46 | 32142685 | |
427 (in isoform 2) | Phosphorylation | - | 2.46 | - | |
427 (in isoform 4) | Phosphorylation | - | 2.46 | - | |
428 (in isoform 2) | Phosphorylation | - | 2.44 | - | |
428 (in isoform 4) | Phosphorylation | - | 2.44 | - | |
429 | Ubiquitination | LDVPEIVISGNGQPR CCCCEEEECCCCCCC | 5.54 | 24816145 | |
430 | Phosphorylation | DVPEIVISGNGQPRR CCCEEEECCCCCCCC | 18.47 | 23186163 | |
432 | Ubiquitination | PEIVISGNGQPRRRS CEEEECCCCCCCCCC | 38.85 | 23000965 | |
433 | Ubiquitination | EIVISGNGQPRRRSI EEEECCCCCCCCCCE | 42.25 | 21890473 | |
439 | Phosphorylation | NGQPRRRSIQDLTVT CCCCCCCCEEEEEEE | 23.84 | 19664994 | |
439 (in isoform 3) | Phosphorylation | - | 23.84 | - | |
444 | Acetylation | RRSIQDLTVTGTEPG CCCEEEEEEECCCCC | 25.06 | 22520462 | |
444 | Phosphorylation | RRSIQDLTVTGTEPG CCCEEEEEEECCCCC | 25.06 | 29255136 | |
446 | Acetylation | SIQDLTVTGTEPGQV CEEEEEEECCCCCCC | 32.90 | 22520462 | |
446 | Phosphorylation | SIQDLTVTGTEPGQV CEEEEEEECCCCCCC | 32.90 | 23927012 | |
446 (in isoform 3) | Phosphorylation | - | 32.90 | - | |
447 | Ubiquitination | IQDLTVTGTEPGQVS EEEEEEECCCCCCCC | 24.60 | 29967540 | |
448 | Acetylation | QDLTVTGTEPGQVSS EEEEEECCCCCCCCC | 29.64 | 22520462 | |
448 | O-linked_Glycosylation | QDLTVTGTEPGQVSS EEEEEECCCCCCCCC | 29.64 | 30059200 | |
448 | Phosphorylation | QDLTVTGTEPGQVSS EEEEEECCCCCCCCC | 29.64 | 23927012 | |
454 | Phosphorylation | GTEPGQVSSRSSSPS CCCCCCCCCCCCCCC | 16.49 | 29255136 | |
454 (in isoform 3) | Phosphorylation | - | 16.49 | - | |
455 | Phosphorylation | TEPGQVSSRSSSPSV CCCCCCCCCCCCCCE | 37.01 | 29255136 | |
455 (in isoform 3) | Phosphorylation | - | 37.01 | - | |
457 | Phosphorylation | PGQVSSRSSSPSVRM CCCCCCCCCCCCEEE | 36.80 | 30576142 | |
458 | Phosphorylation | GQVSSRSSSPSVRMI CCCCCCCCCCCEEEE | 45.20 | 28450419 | |
459 | Phosphorylation | QVSSRSSSPSVRMIT CCCCCCCCCCEEEEE | 23.57 | 30576142 | |
459 | Ubiquitination | QVSSRSSSPSVRMIT CCCCCCCCCCEEEEE | 23.57 | 23000965 | |
460 | Ubiquitination | VSSRSSSPSVRMITT CCCCCCCCCEEEEEC | 38.50 | 21890473 | |
461 | Phosphorylation | SSRSSSPSVRMITTS CCCCCCCCEEEEECC | 25.05 | 28450419 | |
466 | Phosphorylation | SPSVRMITTSGPTSE CCCEEEEECCCCCCC | 12.93 | 23312004 | |
467 | Acetylation | PSVRMITTSGPTSEK CCEEEEECCCCCCCC | 22.29 | 22520462 | |
467 | Phosphorylation | PSVRMITTSGPTSEK CCEEEEECCCCCCCC | 22.29 | 23312004 | |
468 | Phosphorylation | SVRMITTSGPTSEKP CEEEEECCCCCCCCC | 33.84 | 23312004 | |
471 | Phosphorylation | MITTSGPTSEKPTRS EEECCCCCCCCCCCC | 53.71 | 28857561 | |
472 | Phosphorylation | ITTSGPTSEKPTRSH EECCCCCCCCCCCCC | 46.91 | 25159151 | |
474 | Acetylation | TSGPTSEKPTRSHPW CCCCCCCCCCCCCCC | 52.00 | 25953088 | |
474 | Ubiquitination | TSGPTSEKPTRSHPW CCCCCCCCCCCCCCC | 52.00 | 29967540 | |
476 | Phosphorylation | GPTSEKPTRSHPWTP CCCCCCCCCCCCCCC | 56.74 | 23312004 | |
520 | Ubiquitination | CPNSKESMAVFEQHC CCCCHHHHHHHHHHH | 3.75 | 29967540 | |
532 | Ubiquitination | QHCKMAQEYMKVQTE HHHHHHHHHHHHHHH | 37.75 | 24816145 | |
538 | Phosphorylation | QEYMKVQTEIALLLQ HHHHHHHHHHHHHHH | 32.14 | - | |
547 | Ubiquitination | IALLLQRKQELVAEL HHHHHHHHHHHHHHH | 34.85 | 29967540 | |
552 | Ubiquitination | QRKQELVAELDQDEK HHHHHHHHHHCCCHH | 25.02 | 32015554 | |
559 | Ubiquitination | AELDQDEKDQQNTSR HHHCCCHHHHHHHHH | 69.95 | 24816145 | |
562 | Ubiquitination | DQDEKDQQNTSRLVQ CCCHHHHHHHHHHHH | 66.36 | 23000965 | |
563 | Ubiquitination | QDEKDQQNTSRLVQE CCHHHHHHHHHHHHH | 34.10 | 23000965 | |
563 (in isoform 2) | Ubiquitination | - | 34.10 | 21890473 | |
572 | 2-Hydroxyisobutyrylation | SRLVQEHKKLLDENK HHHHHHHHHHHHHCC | 44.35 | - | |
573 | Acetylation | RLVQEHKKLLDENKS HHHHHHHHHHHHCCC | 57.07 | 7662889 | |
579 | Ubiquitination | KKLLDENKSLSTYYQ HHHHHHCCCHHHHHH | 51.21 | 32015554 | |
584 | Phosphorylation | ENKSLSTYYQQCKKQ HCCCHHHHHHHHHHH | 8.90 | - | |
585 | Phosphorylation | NKSLSTYYQQCKKQL CCCHHHHHHHHHHHH | 7.69 | - | |
589 | Ubiquitination | STYYQQCKKQLEVIR HHHHHHHHHHHHHHH | 38.94 | 23000965 | |
590 | Ubiquitination | TYYQQCKKQLEVIRS HHHHHHHHHHHHHHH | 68.68 | 23000965 | |
590 (in isoform 1) | Ubiquitination | - | 68.68 | 21890473 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
178 | T | Phosphorylation | Kinase | MAP3K7 | O43318 | GPS |
184 | T | Phosphorylation | Kinase | MAP3K7 | O43318 | GPS |
187 | T | Phosphorylation | Kinase | M3K7 | O43318 | PhosphoELM |
187 | T | Phosphorylation | Kinase | MAP3K7 | Q62073 | GPS |
192 | S | Phosphorylation | Kinase | MAP3K7 | O43318 | GPS |
- | K | Ubiquitination | E3 ubiquitin ligase | TRIM8 | Q9BZR9 | PMID:22084099 |
- | K | Ubiquitination | E3 ubiquitin ligase | TRAF3 | Q13114 | PMID:26882989 |
- | K | Ubiquitination | E3 ubiquitin ligase | TRAF6 | Q9Y4K3 | PMID:15492226 |
- | K | Ubiquitination | E3 ubiquitin ligase | XIAP | P98170 | PMID:22199232 |
- | K | Ubiquitination | E3 ubiquitin ligase | ITCH | Q96J02 | PMID:22199232 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
63 | K | Phosphorylation |
| 12589052 |
63 | K | ubiquitylation |
| 12589052 |
72 | K | ubiquitylation |
| 22406003 |
184 | T | Acetylation |
| 10838074 |
184 | T | Phosphorylation |
| 10838074 |
187 | T | Acetylation |
| 10838074 |
187 | T | Phosphorylation |
| 10838074 |
187 | T | Phosphorylation |
| 10838074 |
192 | S | Phosphorylation |
| 10838074 |
192 | S | Phosphorylation |
| 10838074 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of M3K7_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-389 AND SER-439, ANDMASS SPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-389; SER-439 ANDTHR-444, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-439 AND SER-455, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-389 AND SER-439, ANDMASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-439, AND MASSSPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-439, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-439, AND MASSSPECTROMETRY. | |
"TAK1 mitogen-activated protein kinase kinase kinase is activated byautophosphorylation within its activation loop."; Kishimoto K., Matsumoto K., Ninomiya-Tsuji J.; J. Biol. Chem. 275:7359-7364(2000). Cited for: PHOSPHORYLATION AT SER-192, AND ENZYME REGULATION. | |
"Phosphorylation-dependent activation of TAK1 mitogen-activatedprotein kinase kinase kinase by TAB1."; Sakurai H., Miyoshi H., Mizukami J., Sugita T.; FEBS Lett. 474:141-145(2000). Cited for: INTERACTION WITH TAB1, PHOSPHORYLATION AT THR-184; THR-187 ANDSER-192, AND ACTIVATION. | |
"Protein phosphatase 6 down-regulates TAK1 kinase activation in theIL-1 signaling pathway."; Kajino T., Ren H., Iemura S., Natsume T., Stefansson B.,Brautigan D.L., Matsumoto K., Ninomiya-Tsuji J.; J. Biol. Chem. 281:39891-39896(2006). Cited for: INTERACTION WITH PP2A AND PPP6C, AND DEPHOSPHORYLATION AT THR-187 BYPP2A AND PPP6C. | |
"The Yersinia enterocolitica effector YopP inhibits host cellsignalling by inactivating the protein kinase TAK1 in the IL-1signalling pathway."; Thiefes A., Wolf A., Doerrie A., Grassl G.A., Matsumoto K.,Autenrieth I., Bohn E., Sakurai H., Niedenthal R., Resch K.,Kracht M.; EMBO Rep. 7:838-844(2006). Cited for: UBIQUITINATION, PHOSPHORYLATION AT THR-187 BY AUTOCATALYSIS, SUBUNIT,AND FUNCTION. |